moderate complexity test | GenomeWeb

moderate complexity test

NEW YORK (GenomeWeb News) – Cepheid said today that the US Food and Drug Administration has categorized Cepheid's Xpert MTB/RIF test as "moderate complexity" under CLIA guidelines.

NEW YORK (GenomeWeb News) – Meridian Bioscience said on Monday that its illumigene Group A Streptococcus and illumigene Group B Streptococcus assays have been recategorized by the US Food and Drug Administration as "moderate complexity" tests under the Clinical Laboratory Improv

NEW YORK (GenomeWeb News) – Cepheid today said that the US Food and Drug Administration has categorized the firm's Xpert CT/NG test as moderate complexity under the Clinical Laboratory Improvement Amendments.

NEW YORK (GenomeWeb News) – Nanosphere said after the close of the market Thursday that the US Food and Drug Administration has designated its Gram-Positive Blood Culture nucleic acid test as a moderate-complexity test under CLIA.

With the new rating, the BD Max GBS Assay "will increase access to cost-effective molecular testing for a broad range of laboratories performing GBS screening," BD said.

The Verigene SP respiratory virus panel is the first of Nanosphere's test to get the moderate complexity designation.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.